Joseph Stringer
Stock Analyst at Needham
(4.48)
# 316
Out of 5,030 analysts
314
Total ratings
48.57%
Success rate
26.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Stringer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics | Maintains: Buy | $22 → $35 | $33.53 | +4.38% | 24 | Oct 10, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $70 → $78 | $73.09 | +6.72% | 24 | Oct 8, 2025 | |
| CDTX Cidara Therapeutics | Maintains: Buy | $74 → $100 | $101.52 | -1.50% | 15 | Sep 24, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $60 → $65 | $47.89 | +35.73% | 18 | Sep 10, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $377 → $478 | $481.67 | -0.76% | 23 | Jul 31, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $133 | $122.81 | +8.30% | 7 | Jul 25, 2025 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $72 → $95 | $110.28 | -13.86% | 25 | Jul 9, 2025 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $28 | $12.96 | +116.05% | 52 | Jun 6, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $14 | $5.78 | +142.21% | 18 | May 22, 2025 | |
| ANNX Annexon | Maintains: Buy | $16 → $11 | $3.15 | +249.21% | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $29 | $24.52 | +18.27% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $416.81 | - | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $42.39 | +112.31% | 17 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.42 | - | 13 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 | $1.57 | +536.94% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $26.01 | - | 8 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $37 | $20.89 | +77.12% | 6 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $14.26 | +26.23% | 2 | Aug 24, 2021 |
Stoke Therapeutics
Oct 10, 2025
Maintains: Buy
Price Target: $22 → $35
Current: $33.53
Upside: +4.38%
Ionis Pharmaceuticals
Oct 8, 2025
Maintains: Buy
Price Target: $70 → $78
Current: $73.09
Upside: +6.72%
Cidara Therapeutics
Sep 24, 2025
Maintains: Buy
Price Target: $74 → $100
Current: $101.52
Upside: -1.50%
Avidity Biosciences
Sep 10, 2025
Maintains: Buy
Price Target: $60 → $65
Current: $47.89
Upside: +35.73%
Alnylam Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $377 → $478
Current: $481.67
Upside: -0.76%
Gilead Sciences
Jul 25, 2025
Upgrades: Buy
Price Target: $133
Current: $122.81
Upside: +8.30%
Rhythm Pharmaceuticals
Jul 9, 2025
Maintains: Buy
Price Target: $72 → $95
Current: $110.28
Upside: -13.86%
Phathom Pharmaceuticals
Jun 6, 2025
Maintains: Buy
Price Target: $28
Current: $12.96
Upside: +116.05%
Vir Biotechnology
May 22, 2025
Reiterates: Buy
Price Target: $14
Current: $5.78
Upside: +142.21%
Annexon
May 13, 2025
Maintains: Buy
Price Target: $16 → $11
Current: $3.15
Upside: +249.21%
May 7, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $24.52
Upside: +18.27%
May 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $416.81
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $90
Current: $42.39
Upside: +112.31%
Mar 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.42
Upside: -
Mar 4, 2025
Downgrades: Hold
Price Target: $10
Current: $1.57
Upside: +536.94%
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $26.01
Upside: -
Jan 24, 2024
Upgrades: Buy
Price Target: $37
Current: $20.89
Upside: +77.12%
Aug 24, 2021
Maintains: Buy
Price Target: $32 → $18
Current: $14.26
Upside: +26.23%